Cost-Effectiveness of Dapagliflozin Compared To Dpp-4 Inhibitors as Triple Therapy In Combination With Metformin and A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective
Abstract
Authors
M. Charokopou H. Vioix L.A. Eddowes M. Griffiths B.G. Verheggen Z. Gabriel K. Tolley